[go: up one dir, main page]

MX2016002198A - Proceso para la preparación de un compuesto. - Google Patents

Proceso para la preparación de un compuesto.

Info

Publication number
MX2016002198A
MX2016002198A MX2016002198A MX2016002198A MX2016002198A MX 2016002198 A MX2016002198 A MX 2016002198A MX 2016002198 A MX2016002198 A MX 2016002198A MX 2016002198 A MX2016002198 A MX 2016002198A MX 2016002198 A MX2016002198 A MX 2016002198A
Authority
MX
Mexico
Prior art keywords
preparing
compound
preparation
compounds
useful
Prior art date
Application number
MX2016002198A
Other languages
English (en)
Other versions
MX369174B (es
Inventor
Michelangelo Scalone
Weidong Liu
Keith L Spencer
Francis Gosselin
Peter J Stengel
Chong Han
Sagar Shakya
GREEN Keena
J Nichols Paul
D Crane Zackary
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MX2016002198A publication Critical patent/MX2016002198A/es
Publication of MX369174B publication Critical patent/MX369174B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invención proporciona procesos de preparación de los mismos útiles en la preparación de compuestos que se pueden utilizar como inhibidores de CHK1.
MX2016002198A 2013-08-22 2014-08-21 Proceso para la preparación de un compuesto. MX369174B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361868933P 2013-08-22 2013-08-22
PCT/US2014/052146 WO2015027092A1 (en) 2013-08-22 2014-08-21 Process for preparing a compound

Publications (2)

Publication Number Publication Date
MX2016002198A true MX2016002198A (es) 2016-09-08
MX369174B MX369174B (es) 2019-10-30

Family

ID=52484170

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016002198A MX369174B (es) 2013-08-22 2014-08-21 Proceso para la preparación de un compuesto.

Country Status (10)

Country Link
US (1) US10329288B2 (es)
EP (1) EP3036227B1 (es)
JP (1) JP6463758B2 (es)
KR (1) KR102325163B1 (es)
CN (1) CN105705499B (es)
AR (1) AR100020A1 (es)
CA (1) CA2921956C (es)
MX (1) MX369174B (es)
RU (1) RU2672725C2 (es)
WO (1) WO2015027092A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA41599A (fr) * 2015-02-26 2018-01-02 Array Biopharma Inc Formes cristallines d'un composé pyrrolopyridine
CN109796349A (zh) * 2019-03-01 2019-05-24 西南石油大学 一种还原芳香硝基化合物制备芳胺类化合物的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69611443T2 (de) 1995-05-19 2001-07-12 Novartis Ag, Basel Verfahren zur katalytischen hydrogenierung von aromatischen nitroverbindungen
AU784297C (en) * 2000-06-26 2007-01-11 Pfizer Products Inc. Pyrrolo(2,3-d)pyrimidine compounds as immunosuppressive agents
WO2003028724A1 (en) 2001-10-04 2003-04-10 Smithkline Beecham Corporation Chk1 kinase inhibitors
GB0330043D0 (en) * 2003-12-24 2004-01-28 Pharmacia Italia Spa Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
SE0401001D0 (sv) * 2004-03-31 2004-03-31 Astrazeneca Ab Chemical process
AR054416A1 (es) * 2004-12-22 2007-06-27 Incyte Corp Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
CA2598639A1 (en) * 2005-02-23 2006-08-31 Coley Pharmaceutical Group, Inc. Hydroxyalkyl substituted imidazonaphthyridines
US8163767B2 (en) * 2005-07-14 2012-04-24 Astellas Pharma Inc. Heterocyclic Janus Kinase 3 inhibitors
EP2242755B1 (en) * 2008-01-08 2012-09-12 Array Biopharma, Inc. Pyrrolopyridines as kinase inhibitors
ES2392014T3 (es) 2008-01-09 2012-12-03 Array Biopharma, Inc. Pirazolopiridinas como inhibidores de la cinasa
CL2009001152A1 (es) * 2008-05-13 2009-10-16 Array Biopharma Inc Compuestos derivados de n-(4-(cicloalquilo nitrogenado-1-il)-1h-pirrolo[2,3-b]piridin-3-il)amida, inhibidores de cinasa; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de una enfermedad proliferativa.
HUE026671T2 (en) 2011-08-18 2016-07-28 Nippon Shinyaku Co Ltd Heterocyclic derivatives as microsomal prostaglandin E synthetase inhibitors (mPGEs)
GB201201566D0 (en) * 2012-01-30 2012-03-14 Vernalis R&D Ltd New chemical compounds

Also Published As

Publication number Publication date
CN105705499A (zh) 2016-06-22
EP3036227B1 (en) 2020-01-08
KR20160043116A (ko) 2016-04-20
JP6463758B2 (ja) 2019-02-06
JP2016528296A (ja) 2016-09-15
RU2672725C2 (ru) 2018-11-19
CA2921956A1 (en) 2015-02-26
KR102325163B1 (ko) 2021-11-11
AR100020A1 (es) 2016-09-07
US10329288B2 (en) 2019-06-25
EP3036227A4 (en) 2017-01-04
CN105705499B (zh) 2018-10-12
US20160200723A1 (en) 2016-07-14
HK1222392A1 (zh) 2017-06-30
WO2015027092A1 (en) 2015-02-26
RU2016110081A (ru) 2017-09-27
MX369174B (es) 2019-10-30
EP3036227A1 (en) 2016-06-29
RU2016110081A3 (es) 2018-05-18
CA2921956C (en) 2021-10-19

Similar Documents

Publication Publication Date Title
MX370649B (es) Proceso para la preparacion de teneligliptina.
IN2013MU00646A (es)
MX2015001506A (es) Proceso e intermediarios para preparar inhibidores de integrasa.
IL246127A0 (en) Process methods for phosphatidylinositol 3-kinase inhibitors
SI3552017T1 (sl) Spojine uporabne kot zaviralci RIPK1
IN2014DN08777A (es)
IL245474B (en) Process for preparing 5-fluoro-1h-pyrazoles
IL245476B (en) Process for the preparation of 5-fluoro-1h-pyrazoles
EP3008049A4 (en) METHOD FOR PRODUCING FURANE COMPOUNDS WITH AT LEAST ONE AMINE FUNCTION
IN2013MU01113A (es)
PH12016501183A1 (en) Novel compound for treatment of severe hypoglycemia
IL229326A (en) Process for making n-iodine-affluent
PH12016501184A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501182A1 (en) Novel compound for treatment of severe hypoglycemia
MX2016002198A (es) Proceso para la preparación de un compuesto.
IN2013MU04056A (es)
IN2013MU03768A (es)
IN2013MU01501A (es)
MY168958A (en) Intermediates and processes for preparing compounds
IN2013CH05395A (es)
IN2013CH05884A (es)
IN2013CH05769A (es)
IN2013MU03841A (es)
IN2013MU03466A (es)
IL240819A0 (en) An improved process for the production of moxonidine

Legal Events

Date Code Title Description
FG Grant or registration